Laboratory Corporation of America Holdings logo

Laboratory Corporation of America HoldingsNYSE: LH

Profile

Sector:

Healthcare

Country:

United States

IPO:

29 March 1990

Next earnings report:

14 February 2025

Last dividends:

29 August 2024

Next dividends:

26 November 2024
$19.09 B
-25%vs. 3y high
96%vs. sector
-15%vs. 3y high
72%vs. sector
-10%vs. 3y high
61%vs. sector
-21%vs. 3y high
31%vs. sector

Price

after hours | Thu, 31 Oct 2024 21:59:14 GMT
$228.27-$2.34(-1.01%)
$3.28 B$3.31 B
$3.28 B$169.30 M

Analysts recommendations

Institutional Ownership

LH Latest News

Labcorp Holdings Inc. (LH) Q3 2024 Earnings Call Transcript
seekingalpha.com24 October 2024 Sentiment: POSITIVE

Labcorp Holdings Inc. (NYSE:LH) will hold its Q3 2024 Earnings Conference Call on October 24, 2024, at 9:00 AM ET. Key participants from the company include Christin O'Donnell, Adam Schechter, and Glenn Eisenberg. Various analysts from firms like Mizuho, JPMorgan, and Citi will also be joining the call.

Compared to Estimates, Labcorp (LH) Q3 Earnings: A Look at Key Metrics
zacks.com24 October 2024 Sentiment: POSITIVE

The main figures for Labcorp (LH) provide an overview of the company's performance for the quarter that ended in September 2024. However, it could be useful to compare some important metrics with Wall Street predictions and the results from the same period last year.

Labcorp beats quarterly estimates on diagnostic test demand
reuters.com24 October 2024 Sentiment: POSITIVE

On Thursday, Labcorp, a laboratory operator, exceeded Wall Street's expectations for its third-quarter profit and revenue, thanks to a strong demand for diagnostic tests.

Labcorp Announces 2024 Third Quarter Results
prnewswire.com24 October 2024 Sentiment: POSITIVE

Labcorp has reported its third-quarter results for 2024, showing revenue of $3.28 billion, an increase from $3.06 billion last year. However, the diluted EPS decreased to $2.00 from $2.11, while adjusted EPS rose slightly to $3.50 from $3.38. The company also updated its full-year guidance, projecting revenue growth of 6.6% to 7.3% and adjusted EPS between $14.30 and $14.70, reflecting a $0.10 decrease in the midpoint due to weather-related impacts.

LH Beats on Q3 Earnings, Raises Revenue Guidance Midpoint, Stock Gains
zacks.com24 October 2024 Sentiment: POSITIVE

Labcorp has exceeded expectations for earnings and revenues in the third quarter, starting the fourth quarter of 2024 with strong momentum.

Seeking Clues to Labcorp (LH) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics
zacks.com21 October 2024 Sentiment: POSITIVE

Instead of just focusing on Wall Street's predictions for Labcorp's (LH) earnings, let's explore some important metrics to better understand how the company might perform in the quarter that ended in September 2024. This will give us a clearer picture of its potential results.

Labcorp (LH) Reports Next Week: Wall Street Expects Earnings Growth
zacks.com17 October 2024 Sentiment: NEUTRAL

Labcorp (LH) lacks the necessary elements that could lead to a strong earnings report in its next announcement. Be ready for the important expectations.

Labcorp Stock Gains From Biopharma Business Amid FX Woe
zacks.com07 October 2024 Sentiment: POSITIVE

LH is in a strong position for future success in Cell & Gene Therapy. They are also moving into the consumer market and growing internationally through their specialty testing and biopharma sectors.

Should You Continue to Retain LH Stock in Your Portfolio?
zacks.com25 September 2024 Sentiment: POSITIVE

Labcorp is growing its testing services in fast-developing areas, forming partnerships, and concentrating on improving operations, which brings a sense of hope.

Labcorp to Announce Third Quarter Financial Results on October 24, 2024
prnewswire.com24 September 2024 Sentiment: POSITIVE

BURLINGTON, N.C., Sept. 24, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a leading provider of advanced laboratory services, is set to announce its financial results for the third quarter of 2024 before the market opens on Thursday, October 24, 2024.

What type of business is Laboratory Corporation of America Holdings?

Laboratory Corporation of America Holdings is a global company in the field of natural sciences. It provides comprehensive clinical laboratory services and drug development services through its LabCorp Diagnostics (LCD) and Covance Drug Development (CDD) segments. The company was founded in 1971, headquartered in Burlington, North Carolina. LabCorp provides diagnostic, drug, and technology solutions for more than 160 million clients per year, or over 3 million per week. The company also supports clinical trials in approximately 100 countries through its industry-leading central laboratories, preclinical and clinical development, generating more safety and efficacy data to support drug approvals than any other company.

What sector is Laboratory Corporation of America Holdings in?

Laboratory Corporation of America Holdings is in the Healthcare sector

What industry is Laboratory Corporation of America Holdings in?

Laboratory Corporation of America Holdings is in the Diagnostics & Research industry

What country is Laboratory Corporation of America Holdings from?

Laboratory Corporation of America Holdings is headquartered in United States

When did Laboratory Corporation of America Holdings go public?

Laboratory Corporation of America Holdings initial public offering (IPO) was on 29 March 1990

What is Laboratory Corporation of America Holdings website?

https://www.labcorp.com

Is Laboratory Corporation of America Holdings in the S&P 500?

Yes, Laboratory Corporation of America Holdings is included in the S&P 500 index

Is Laboratory Corporation of America Holdings in the NASDAQ 100?

No, Laboratory Corporation of America Holdings is not included in the NASDAQ 100 index

Is Laboratory Corporation of America Holdings in the Dow Jones?

No, Laboratory Corporation of America Holdings is not included in the Dow Jones index

When was Laboratory Corporation of America Holdings the previous earnings report?

No data

When does Laboratory Corporation of America Holdings earnings report?

The next expected earnings date for Laboratory Corporation of America Holdings is 14 February 2025